Clinical Trial

A Prospective Multicenter Study: Ivosimab + Chemotherapy as Neoadjuvant for Resectable pMMR/MSS CRC Liver Mets

Name: A Prospective Multicenter Study: Ivosimab + Chemotherapy as Neoadjuvant for Resectable pMMR/MSS CRC Liver Mets — clinical trial record (NCT06972498)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The population receiving ivosimab combined with chemotherapy for neoadjuvant treatment of colorectal cancer liver metastasis.

Trial Details

NCT Number	NCT06972498
Lead Sponsor	The Fourth Affiliated Hospital of Zhejiang University School of Medicine Collaborators: Zhejiang University
Conditions	Colorectal Cancer With Liver Metastasis
Enrollment	35 participants
Start Date	2025-07-01
Primary Completion	2027-12-30 (estimated)
Study Completion	2027-12-30 (estimated)
Updated on ClinicalTrials.gov	2025-05-15